Purchases and Sales Made in Q4 2024 in Protagonist Therapeutics, Inc (PTGX)
This table provides information about the institutional ownership of Protagonist Therapeutics, Inc (PTGX) during Q4 2024. The information is specifically focused on institutions that hold shares of Protagonist Therapeutics, Inc.
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Feb 14, 2025
Q4 2024
|
Nuveen Asset Management, LLC
Chicago, IL |
SELL
|
- |
-80.9K- 34.85% |
$3.11M - $3.92M
|
151K
$5.86M
|
|
|
Feb 14, 2025
Q4 2024
|
Morgan Stanley
New York, NY |
SELL
|
- |
-88.3K- 14.05% |
$3.4M - $4.28M
|
540K
$20.9M
|
|
|
Jan 29, 2025
Q4 2024
|
Allspring Global Investments Holdings, LLC
|
SELL
|
- |
-97.9K- 94.25% |
$3.77M - $4.74M
|
5.98K
$232K
|
|
|
Feb 14, 2025
Q4 2024
|
Algert Global LLC
San Francisco, CA |
SELL
|
- |
-98K- 84.68% |
$3.77M - $4.74M
|
17.7K
$687K
|
|
|
Feb 14, 2025
Q4 2024
|
Perceptive Advisors LLC
New York, NY |
SELL
|
- |
-103K- 7.49% |
$3.96M - $4.98M
|
1.27M
$49.3M
|
|
|
Feb 14, 2025
Q4 2024
|
Driehaus Capital Management LLC
Chicago, IL |
SELL
|
- |
-106K- 23.72% |
$4.07M - $5.12M
|
340K
$13.2M
|
|
|
Feb 13, 2025
Q4 2024
|
Marshall Wace, LLP
London, X0 |
SELL
|
- |
-296K- 93.75% |
$11.4M - $14.3M
|
19.7K
$764K
|
|
|
Feb 14, 2025
Q4 2024
|
Jefferies Financial Group Inc.
New York, NY |
SELL
|
- |
-325K- 17.92% |
$12.5M - $15.7M
|
1.49M
$57.7M
|